Topic: "Finerenone in Patients With
Chronic Kidney Disease and
Type 2 Diabetes by Sodium–Glucose
Cotransporter 2 Inhibitor Treatment:
The FIDELITY Analysis"
Objective(s): "Finerenone reduced the risk of kidney and cardiovascular events in people with
chronic kidney disease (CKD) and type 2 diabetes in the FIDELIO-DKD and FIGARODKD
phase 3 studies. Effects of finerenone on outcomes in patients taking sodium–
glucose cotransporter 2 inhibitors (SGLT2is) were evaluated in a prespecified pooled
analysis of these studies."
Speaker: Dr. Katherine Lewis
- 1.00 AMA PRA Category 1 Credit(s)™The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance